| Primary |
| Hypertension |
50.4% |
| Product Used For Unknown Indication |
17.1% |
| Drug Use For Unknown Indication |
8.7% |
| Blood Pressure Increased |
4.3% |
| Essential Hypertension |
2.6% |
| Blood Pressure |
2.5% |
| Diabetes Mellitus |
1.9% |
| Asthma |
1.3% |
| Pneumonia |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Atrial Fibrillation |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Blood Pressure Abnormal |
1.0% |
| Osteoporosis |
1.0% |
| Hiv Infection |
0.9% |
| Pain |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Hypercholesterolaemia |
0.7% |
| Cardiovascular Disorder |
0.7% |
| Immunosuppressant Drug Therapy |
0.7% |
|
| Completed Suicide |
13.3% |
| Oedema Peripheral |
10.2% |
| Death |
7.8% |
| Drug Ineffective |
7.6% |
| Overdose |
4.9% |
| Toxicity To Various Agents |
4.9% |
| Rash |
4.7% |
| Malaise |
4.4% |
| Dizziness |
4.2% |
| Renal Failure Acute |
4.2% |
| Suicide Attempt |
4.2% |
| Hypotension |
4.0% |
| Joint Swelling |
4.0% |
| Headache |
3.3% |
| Product Substitution Issue |
3.3% |
| Vomiting |
3.3% |
| Blood Pressure Inadequately Controlled |
3.1% |
| Blood Pressure Increased |
2.9% |
| Drug Level Increased |
2.9% |
| Feeling Abnormal |
2.9% |
|
| Secondary |
| Hypertension |
35.1% |
| Product Used For Unknown Indication |
31.6% |
| Drug Use For Unknown Indication |
9.3% |
| Diabetes Mellitus |
2.4% |
| Type 2 Diabetes Mellitus |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Convulsion |
1.7% |
| Essential Hypertension |
1.5% |
| Blood Pressure |
1.4% |
| Spinal Osteoarthritis |
1.4% |
| Blood Pressure Increased |
1.3% |
| Ingrowing Nail |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Arthralgia |
1.3% |
| Pain |
1.3% |
| Blood Triglycerides Increased |
1.2% |
| Depression |
1.1% |
| Suicide Attempt |
1.1% |
| Atrial Fibrillation |
1.0% |
| Prophylaxis |
1.0% |
|
| Oedema Peripheral |
8.6% |
| Syncope |
8.6% |
| Renal Failure |
7.9% |
| Renal Failure Acute |
5.7% |
| Drug Ineffective |
5.4% |
| Completed Suicide |
4.8% |
| Nervousness |
4.8% |
| Rhabdomyolysis |
4.8% |
| Weight Decreased |
4.8% |
| Malaise |
4.4% |
| Vomiting |
4.4% |
| Death |
4.1% |
| Hypertension |
4.1% |
| Pyrexia |
4.1% |
| Weight Increased |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Abdominal Distension |
3.8% |
| Blood Pressure Increased |
3.8% |
| Hypotension |
3.8% |
| Renal Impairment |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.8% |
| Hypertension |
20.6% |
| Drug Use For Unknown Indication |
14.9% |
| Rheumatoid Arthritis |
7.8% |
| Diabetes Mellitus |
3.7% |
| Prophylaxis |
3.2% |
| Pain |
2.5% |
| Type 2 Diabetes Mellitus |
2.3% |
| Osteoporosis |
2.2% |
| Hepatitis C |
1.9% |
| Depression |
1.7% |
| Insomnia |
1.6% |
| Multiple Myeloma |
1.5% |
| Renal Transplant |
1.5% |
| Constipation |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Hyperlipidaemia |
1.3% |
| Hiv Infection |
1.2% |
| Blood Pressure |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
|
| Vomiting |
12.3% |
| Renal Failure Acute |
7.2% |
| Rhabdomyolysis |
7.0% |
| Death |
6.6% |
| Pyrexia |
6.6% |
| Pneumonia |
5.6% |
| White Blood Cell Count Decreased |
5.4% |
| Weight Decreased |
5.3% |
| Interstitial Lung Disease |
4.2% |
| Thrombocytopenia |
4.2% |
| Renal Failure |
4.0% |
| Nausea |
3.9% |
| Sepsis |
3.9% |
| Weight Increased |
3.8% |
| Drug Ineffective |
3.7% |
| Dyspnoea |
3.7% |
| Syncope |
3.4% |
| Rash |
3.3% |
| Myocardial Infarction |
3.1% |
| Hypoglycaemia |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
32.7% |
| Hypertension |
26.8% |
| Coronary Artery Disease |
5.9% |
| Hiv Infection |
5.2% |
| Mental Disorder |
3.3% |
| Blood Pressure Increased |
3.0% |
| Diabetes Mellitus |
2.2% |
| Herpes Simplex |
2.2% |
| Ill-defined Disorder |
2.2% |
| Drug Use For Unknown Indication |
1.9% |
| Hyperlipidaemia |
1.9% |
| Lyme Disease |
1.9% |
| Lymphangitis |
1.5% |
| Onychomycosis |
1.5% |
| Pain |
1.5% |
| Peripheral Arterial Occlusive Disease |
1.5% |
| Splenectomy |
1.5% |
| Anticoagulant Therapy |
1.1% |
| Arthritis |
1.1% |
| Cerebrovascular Accident |
1.1% |
|
| Drug Interaction |
25.4% |
| Gait Disturbance |
10.2% |
| Oedema Peripheral |
8.5% |
| Pain |
5.1% |
| Renal Failure Acute |
5.1% |
| Rhabdomyolysis |
5.1% |
| Salivary Gland Enlargement |
5.1% |
| Wrist Fracture |
5.1% |
| Gastrointestinal Haemorrhage |
3.4% |
| Oedema |
3.4% |
| Pruritus |
3.4% |
| Serotonin Syndrome |
3.4% |
| Transaminases Increased |
3.4% |
| Vasogenic Cerebral Oedema |
3.4% |
| Arthropathy |
1.7% |
| Condition Aggravated |
1.7% |
| Dementia |
1.7% |
| Hepatocellular Damage |
1.7% |
| Lethargy |
1.7% |
| Mixed Liver Injury |
1.7% |
|
